1. Home
  2. LXU vs PRAX Comparison

LXU vs PRAX Comparison

Compare LXU & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXU
  • PRAX
  • Stock Information
  • Founded
  • LXU 1968
  • PRAX 2015
  • Country
  • LXU United States
  • PRAX United States
  • Employees
  • LXU N/A
  • PRAX N/A
  • Industry
  • LXU Major Chemicals
  • PRAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXU Industrials
  • PRAX Health Care
  • Exchange
  • LXU Nasdaq
  • PRAX Nasdaq
  • Market Cap
  • LXU 545.6M
  • PRAX 599.7M
  • IPO Year
  • LXU 1969
  • PRAX 2020
  • Fundamental
  • Price
  • LXU $8.21
  • PRAX $46.32
  • Analyst Decision
  • LXU Strong Buy
  • PRAX Strong Buy
  • Analyst Count
  • LXU 3
  • PRAX 11
  • Target Price
  • LXU $9.67
  • PRAX $114.73
  • AVG Volume (30 Days)
  • LXU 486.1K
  • PRAX 299.7K
  • Earning Date
  • LXU 07-30-2025
  • PRAX 08-12-2025
  • Dividend Yield
  • LXU N/A
  • PRAX N/A
  • EPS Growth
  • LXU N/A
  • PRAX N/A
  • EPS
  • LXU N/A
  • PRAX N/A
  • Revenue
  • LXU $527,628,000.00
  • PRAX $8,122,000.00
  • Revenue This Year
  • LXU $8.50
  • PRAX N/A
  • Revenue Next Year
  • LXU $1.09
  • PRAX $6,358.50
  • P/E Ratio
  • LXU N/A
  • PRAX N/A
  • Revenue Growth
  • LXU N/A
  • PRAX 270.02
  • 52 Week Low
  • LXU $4.88
  • PRAX $26.70
  • 52 Week High
  • LXU $10.40
  • PRAX $91.83
  • Technical
  • Relative Strength Index (RSI)
  • LXU 59.15
  • PRAX 63.87
  • Support Level
  • LXU $7.72
  • PRAX $40.93
  • Resistance Level
  • LXU $8.93
  • PRAX $44.40
  • Average True Range (ATR)
  • LXU 0.32
  • PRAX 2.26
  • MACD
  • LXU -0.07
  • PRAX -0.08
  • Stochastic Oscillator
  • LXU 47.84
  • PRAX 95.12

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: